PANORAMA ACTUEL DES MEDICAMENTS HYPOLIPEMIANTSHELLER F; HARVENGT C.1980; BULL. SOC. PHARM. LILLE; ISSN 0366-3507; FRA; DA. 1980; VOL. 36; NO 3-4; PP. 209-219; BIBL. 3 P.Article

LES MEDICAMENTS HYPOLIPIDEMIANTSBONTE JP; BERTHELOT P.1980; BULL. SOC. PHARM. LILLE; ISSN 0366-3507; FRA; DA. 1980; VOL. 36; NO 3-4; PP. 243-262; BIBL. 2 P.Article

PLAFIBRIDE TOLERANCE TRIAL IN HEATHY VOLUNTEERSDALMAU J; VICENS B; ZAPATERO J et al.1981; ARZNEIM.-FORSCH.; ISSN 0004-4172; DEU; DA. 1981; VOL. 31; NO 10; PP. 1845-1849; ABS. GER; BIBL. 8 REF.Article

SELECTED ANIMAL MODELS FOR SYSTEMATIC ANTI-ATHEROSCLEROTIC DRUG DEVELOPMENTDAY CE; SCHURR PE; PHILLIPS WA et al.1978; ADV. EXPER. MED. BIOL.; USA; DA. 1978; VOL. 109; PP. 277-283; BIBL. 14 REF.Conference Paper

CLOFIBRAT-VERBOT-WAS NUN. = CLOFIBRATE UNTERDIT: QU'EN EST-IL MAINTENANTSCHWARTZKOPFF W.1979; MUENCH. MED. WSCHR.; DEU; DA. 1979; VOL. 121; NO 15; PP. 529-533; ABS. ENG; BIBL. 27 REF.Article

ASPECTS BIOCHIMIQUES ET EXPERIMENTAUX DE LA PHARMACOLOGIE DES MEDICAMENTS HYPOLIPIDEMIANTSJACOTOT B.1979; SEM. HOP.; FRA; DA. 1979; VOL. 55; NO 41-42; PP. 1947-1955; ABS. ENG; BIBL. 28 REF.Article

LE MODE D'ACTION DES MEDICAMENTS HYPOLIPEMIANTS.LOEPER J; LOEPER J et al.ROUFFY J; LOEPER J; LOEPER J et al.1976; BULL. ACAD. NATION. MED.; FR.; DA. 1976; VOL. 160; NO 5; PP. 434-438Article

NACH DEM CLOFIBRAT-VERBOT VERFUEGBARE LIPIDSENKER. KLINISCH-PHARMAKOLOGISCHE SICHTUNG = SELECTION DES HYPOLIPEMIANTS APRES LE VERDICT DU CLOFIBRATE. POINTS DE VUE CLINIQUES ET PHARMACOLOGIQUESMERTZ DP.1979; FORTSCHR. D. MED.; DEU; DA. 1979; VOL. 97; NO 15; PP. 695-698; ABS. ENG; BIBL. 24 REF.Article

HYPOCHOLESTEROLEMIC EFFECTS OF CHITOSAN IN CHOLESTEROL-FED RATSSUGANO M; FUJIKAWA T; HITATSUJI Y et al.1978; NUTRIT. REP. INTERNATION.; USA; DA. 1978; VOL. 18; NO 5; PP. 531-537; BIBL. 19 REF.Article

TOLERANCE HEPATIQUE DU PROCETOFENEROSSI A.1978; NOUV. PRESSE MED.; FRA; DA. 1978; VOL. 7; NO 35; PP. 3153Article

A REAPPRAISAL OF THE MECHANISMS OF HYPOCHOLESTEROLEMIC ACTION OF THERAPEUTIC AGENTSSODHI HS; KUDCHODKAR BJ; CLIFFORD C et al.1978; ADV. EXPER. MED. BIOL.; USA; DA. 1978; VOL. 109; PP. 331-345; BIBL. 33 REF.Conference Paper

TEXICOLOGICAL STUDIES OF PLAFIBRIDE. IV: INTERACTION OF PLAFIBRIDE WITH OTHER DRUGSZAPATERO J; BASI N; VILAGELIU J et al.1981; ARZNEIM.-FORSCH.; ISSN 0004-4172; DEU; DA. 1981; VOL. 31; NO 10; PP. 1835-1838; ABS. GER; BIBL. 9 REF.Article

EINFLUSS VON BEZAFIBRAT AUF DEN KOHLENHYDRATSTOFFWECHSEL VON 17 DIABETIKERN MIT HYPERLIPIDAEMIE = INFLUENCE DU BEZAFIBRATE SUR LE METABOLISME DES GLUCIDES DE 17 DIABETIQUES AVEC HYPERLIPIDEMIESTRATMANN FW; HOLLER HD; HOFMANN H et al.1981; MED. WELT; ISSN 0025-8512; DEU; DA. 1981; VOL. 32; NO 8; PP. 268-271; BIBL. 14 REF.Article

THE PHENOMENON OF REGRESSION TO THE MEAN AND CLINICAL INVESTIGATION OF BLOOD CHOLESTEROL LOWERING DRUGSBOISSEL JP; DUPERAT B; LEIZOROVICZ A et al.1980; EUROP. J. CLIN. PHARMACOL.; DEU; DA. 1980; VOL. 17; NO 3; PP. 227-230; BIBL. 4 REF.Article

ANTICOAGULANT AND ANTILIPEMIC ACTIVITIES OF A HEPARIN PROTEOGLYCAN FROM BOVINE INTESTINAL MUCOSASEETHANATHAN P; EHRLICH K.1980; THROMB. RES.; ISSN 0049-3848; USA; DA. 1980; VOL. 19; NO 1-2; PP. 95-102; BIBL. 13 REF.Article

DISPOSITION PHARMACOKINETICS OF BEZAFIBRATE IN MANABSHAGEN U; BABLOK W; KOCH K et al.1979; EUROP. J. CLIN. PHARMACOL.; DEU; DA. 1979; VOL. 16; NO 1; PP. 31-38; ABS. ENG; BIBL. 22 REF.Article

EFFECT OF CLOFIBRATE ON THE PHOSPHOLIPID BIOSYNTHESIS IN RAT LIVERCATALAN RE; CASTILLON MP; PRIEGO JG et al.1979; EXPERIENTIA; CHE; DA. 1979; VOL. 35; NO 7; PP. 859-860; BIBL. 16 REF.Article

EFFET HYPOLIPIDEMIANT DE LA CHOLESTYRAMINE CHEZ LES SUJETS ATTEINTS D'UNE HYPERLIPOPROTEINEMIE DE TYPE IISAUVANET JP; DROUIN P; MEJEAN L et al.1978; THERAPIE; FRA; DA. 1978; VOL. 33; NO 5; PP. 615-622; ABS. ENG; BIBL. 15 REF.Article

WECHSELWIRKUNGEN BEI BEHANDLUNG MIT HYPOLIPIDAEMIKA UND URIKOSTATIKA. = INTERACTIONS DANS LE TRAITEMENT PAR HYPOLIPEMIANTS ET URICOSTATIQUESSCHWANDT P.1978; THERAPIEWOCHE; DTSCH.; DA. 1978; VOL. 28; NO 16; PP. 3182-3184; BIBL. 8 REF.Article

ETUDE PHARMACOCINETIQUE DE L'ACIDE CLOFIBRIQUE CHEZ LE CRABE PACHYGRAPSUS MARMORATUS FABRICIUS (DECAPODE, BRACHYOURE).LAUTIER J; CHANAL JL; GUIBERT J et al.1977; C.R. ACAD. SCI., D; FR.; DA. 1977; VOL. 284; NO 15; PP. 1473-1475; ABS. ANGL.; BIBL. 2 REF.Article

INFLUENCE DE PRODUITS HYPOLIPEMIANTS (CLOFIBRATE ET PROCETOFENE) SUR LE METABOLISME DES CHYLOMICRONS CHEZ LE RAT.BOURDEAUX AM.1977; ; S.L.; DA. 1977; PP. 1-95; BIBL. 7 P.; (THESE DOCT. 3E. CYCLE, SPEC. BIOL. APPL., OPTION NUTR.; DIJON)Thesis

SEPARATION DE PRODUITS HYPOCHOLESTEROLEMIANT A PARTIR DE FLAMMULINA VELUTIPESARAKAWA N; MUKOHYAMA H; NAKAI M et al.1977; J. JAP. SOC. FOOD NUTRIT.; JAP.; DA. 1977; VOL. 30; NO 1; PP. 35-38; ABS. ANGL.; BIBL. 5 REF.Article

BIOAVAILABILITY AND PHARMACOKINETICS IN MAN IN ACIPIMOX: A NEW ANTILIPOLYTIC AND HYPOLIPENIC AGENTMUSATTI L; MAGGI E; MORO E et al.1981; J. INT. MED. RES.; ISSN 0300-0605; GBR; DA. 1981; VOL. 9; NO 5; PP. 381-386; BIBL. 7 REF.Article

DECARBOXYLATION KINETICS OF 5-(TETRADECYLOXY)-2-FUROIC ACIDCARSTENSEN JT; KOTHARI RC.1980; J. PHARM. SCI.; USA; DA. 1980; VOL. 69; NO 1; PP. 123-124; BIBL. 12 REF.Article

DRUGS AFFECTING LIPID METABOLISMMEINERTZ H; FAERGEMAN O.1980; SIDE EFF. DRUGS ANN.; NLD; DA. 1980; VOL. 4; PP. 316-321; BIBL. 12 REF.Article